ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.:…
Recalling firm: ActiPharma, Inc.
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Jan 16, 2024.
Check your package
Compare the exact product and package details with the label you have.
363102217104FDA code information
Lot 13309, Exp: 01/26
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 363102217104 | ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104. |
Original FDA recall reason
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Recall details
- Recall number
- F-0463-2024
- Event ID
- 93210
- FDA status
- Terminated
- Initiated
- Sep 28, 2023
- Reported
- Nov 29, 2023
- Classified
- Nov 17, 2023
- Terminated
- Jan 16, 2024
- Quantity
- 607 bottles of 100 tablets each
- Location
- Guaynabo, PR, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Domestic distribution, in Puerto Rico.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.